Css LLC Intra Cellular Therapies, Inc. Put Options Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $1.38 Million - $1.7 Million	31,300 Added 263.03%	43,200 $2.29 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $1.95 Million - $2.74 Million	-45,600 Reduced 79.3%	11,900 $554,000
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $275,200 - $420,096	6,400 Added 12.52%	57,500 $3.28 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $313,794 - $502,929	8,100 Added 18.84%	51,100 $3.13 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $1.3 Million - $1.98 Million	37,000 Added 616.67%	43,000 $2.25 Million
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $252,560 - $323,982	-8,200 Reduced 57.75%	6,000 $204,000
Q3 2020 Nov 16, 2020	SELL	$17.61 - $31.86 $193,710 - $350,460	-11,000 Reduced 43.65%	14,200 $365,000
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $31,570 - $58,608	-2,200 Reduced 8.03%	25,200 $647,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $198,924 - $1.05 Million	27,400 New	27,400 $941,000

380

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.